Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data.

Boulet S, Ursino M, Thall P, Landi B, Lepère C, Pernot S, Burgun A, Taieb J, Zaanan A, Zohar S, Jannot AS.

Stat Methods Med Res. 2019 Apr 9:962280219841082. doi: 10.1177/0962280219841082. [Epub ahead of print]

PMID:
30963815
2.

Pharmaceutical interventions to improve safety of chemotherapy-treated cancer patients: A cross-sectional study.

Daupin J, Perrin G, Lhermitte-Pastor C, Loustalot MC, Pernot S, Savoldelli V, Thibault C, Landi B, Sabatier B, Caudron E.

J Oncol Pharm Pract. 2019 Jul;25(5):1195-1203. doi: 10.1177/1078155219826344. Epub 2019 Jan 28.

PMID:
30691354
3.

5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.

Pernot S, Velut G, Kourie RH, Amouyal G, Sapoval M, Pointet AL, Landi B, Zaimi Y, Lepère C, Pellerin O, Taieb J.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):255-260. doi: 10.1016/j.clinre.2017.11.004. Epub 2017 Dec 7.

PMID:
29233520
4.

Graphene Strained by Defects.

Robinson JT, Zalalutdinov MK, Cress CD, Culbertson JC, Friedman AL, Merrill A, Landi BJ.

ACS Nano. 2017 May 23;11(5):4745-4752. doi: 10.1021/acsnano.7b00923. Epub 2017 May 8.

PMID:
28463478
5.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, Perniceni T, Landi B, Berger A, Isambert N, Domont J, Bonvalot S, Terrier P, Adam J, Coindre JM, Emile JF, Poirier-Colame V, Chaba K, Rocha B, Caignard A, Toubert A, Enot D, Koch J, Marabelle A, Lambert M, Caillat-Zucman S, Leyvraz S, Auclair C, Vivier E, Eggermont A, Borg C, Blay JY, Le Cesne A, Mir O, Zitvogel L.

Oncoimmunology. 2016 Apr 25;6(1):e1137418. doi: 10.1080/2162402X.2015.1137418. eCollection 2017.

6.

Removal of sodium dodecyl sulfate surfactant from aqueous dispersions of single-wall carbon nanotubes.

Rossi JE, Soule KJ, Cleveland E, Schmucker SW, Cress CD, Cox ND, Merrill A, Landi BJ.

J Colloid Interface Sci. 2017 Jun 1;495:140-148. doi: 10.1016/j.jcis.2017.01.117. Epub 2017 Feb 2.

PMID:
28193512
7.

Modification of Silver/Single-Wall Carbon Nanotube Electrical Contact Interfaces via Ion Irradiation.

Cox ND, Cress CD, Rossi JE, Puchades I, Merrill A, Franklin AD, Landi BJ.

ACS Appl Mater Interfaces. 2017 Mar 1;9(8):7406-7411. doi: 10.1021/acsami.6b14041. Epub 2017 Feb 14.

PMID:
28157281
8.

Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice.

Netter J, Douard R, Durdux C, Landi B, Berger A, Taieb J.

Clin Res Hepatol Gastroenterol. 2016 Nov;40(5):546-552. doi: 10.1016/j.clinre.2016.03.004. Epub 2016 May 2. Review.

PMID:
27156922
9.

Carbon Nanotube Thin-Film Antennas.

Puchades I, Rossi JE, Cress CD, Naglich E, Landi BJ.

ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20986-92. doi: 10.1021/acsami.6b05146. Epub 2016 Aug 4.

PMID:
27454334
10.

Enhanced Electrical Conductivity in Extruded Single-Wall Carbon Nanotube Wires from Modified Coagulation Parameters and Mechanical Processing.

Bucossi AR, Cress CD, Schauerman CM, Rossi JE, Puchades I, Landi BJ.

ACS Appl Mater Interfaces. 2015 Dec 16;7(49):27299-305. doi: 10.1021/acsami.5b08668. Epub 2015 Dec 3.

PMID:
26632650
11.

Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.

Diouf M, Filleron T, Pointet AL, Dupont-Gossard AC, Malka D, Artru P, Gauthier M, Lecomte T, Aparicio T, Thirot-Bidault A, Lobry C, Fein F, Dubreuil O, Landi B, Zaanan A, Taieb J, Bonnetain F.

Qual Life Res. 2016 Jul;25(7):1713-23. doi: 10.1007/s11136-015-1198-x. Epub 2015 Nov 28.

PMID:
26615615
12.

Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study.

Cézé N, Charachon A, Locher C, Aparicio T, Mitry E, Barbieux JP, Landi B, Dorval E, Moussata D, Lecomte T.

Clin Res Hepatol Gastroenterol. 2016 Apr;40(2):230-8. doi: 10.1016/j.clinre.2015.09.004. Epub 2015 Oct 21.

PMID:
26500200
13.

Effectiveness of emergency cerclage in cervical insufficiency.

Ciavattini A, Delli Carpini G, Boscarato V, Febi T, Di Giuseppe J, Landi B.

J Matern Fetal Neonatal Med. 2016;29(13):2088-92. doi: 10.3109/14767058.2015.1075202. Epub 2015 Aug 28.

PMID:
26365717
14.

Preeclampsia: what could happen in a subsequent pregnancy?

Giannubilo SR, Landi B, Ciavattini A.

Obstet Gynecol Surv. 2014 Dec;69(12):747-62. doi: 10.1097/OGX.0000000000000126. Review.

PMID:
25503109
15.

Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).

Trouilloud I, Dupont-Gossard AC, Malka D, Artru P, Gauthier M, Lecomte T, Aparicio T, Thirot-Bidault A, Lobry C, Asnacios A, Manet-Lacombe S, Fein F, Dubreuil O, Landi B, Zaanan A, Bonnetain F, Taïeb J.

Eur J Cancer. 2014 Dec;50(18):3116-24. doi: 10.1016/j.ejca.2014.09.015. Epub 2014 Oct 17.

PMID:
25454414
16.

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.

Hebbar M, Chibaudel B, André T, Mineur L, Smith D, Louvet C, Dutel JL, Ychou M, Legoux JL, Mabro M, Faroux R, Auby D, Brusquant D, Khalil A, Truant S, Hadengue A, Dalban C, Gayet B, Paye F, Pruvot FR, Bonnetain F, Landi B, Flesch M, Carola E, Martin P, Vaillant E, de Gramont A; Group Coopérateur Multidisciplinaire en Oncologie (GERCOR) Group.

Ann Oncol. 2015 Feb;26(2):340-7. doi: 10.1093/annonc/mdu539. Epub 2014 Nov 17. Erratum in: Ann Oncol. 2015 May;26(5):1040. Taieb, J [removed]; Brucker, P [removed].

PMID:
25403578
17.

Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy.

Laurent-Puig P, Pekin D, Normand C, Kotsopoulos SK, Nizard P, Perez-Toralla K, Rowell R, Olson J, Srinivasan P, Le Corre D, Hor T, El Harrak Z, Li X, Link DR, Bouché O, Emile JF, Landi B, Boige V, Hutchison JB, Taly V.

Clin Cancer Res. 2015 Mar 1;21(5):1087-97. doi: 10.1158/1078-0432.CCR-14-0983. Epub 2014 Sep 23.

18.

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG).

Duffaud F, Meeus P, Bachet JB, Cassier P, Huynh TK, Boucher E, Bouché O, Moutardier V, le Cesne A, Landi B, Marchal F, Bay JO, Bertucci F, Spano JP, Stoeckle E, Collard O, Chaigneau L, Isambert N, Lebrun-Ly V, Mancini J, Blay JY, Bonvalot S.

Eur J Surg Oncol. 2014 Oct;40(10):1369-75. doi: 10.1016/j.ejso.2014.04.011. Epub 2014 May 28.

PMID:
24994075
19.

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.

Manceau G, Imbeaud S, Thiébaut R, Liébaert F, Fontaine K, Rousseau F, Génin B, Le Corre D, Didelot A, Vincent M, Bachet JB, Chibaudel B, Bouché O, Landi B, Bibeau F, Leroy K, Penault-Llorca F, Van Laethem JL, Demetter P, Tejpar S, Rossi S, Mosakhani N, Osterlund P, Ristamäki R, Sarhadi V, Knuutila S, Boige V, André T, Laurent-Puig P.

Clin Cancer Res. 2014 Jun 15;20(12):3338-47. doi: 10.1158/1078-0432.CCR-13-2750. Epub 2014 Apr 25.

20.

Amniotic coenzyme Q10: is it related to pregnancy outcomes?

Giannubilo SR, Tiano L, Ciavattini A, Landi B, Carnevali P, Principi F, Littarru GP, Mazzanti L.

Antioxid Redox Signal. 2014 Oct 10;21(11):1582-6. doi: 10.1089/ars.2014.5936. Epub 2014 Jun 25.

21.

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy.

Portal A, Pernot S, Siauve N, Landi B, Lepère C, Colussi O, Rougier P, Zaanan A, Verrière B, Taieb J.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):e23-6. doi: 10.1016/j.clinre.2014.01.005. Epub 2014 Feb 18.

PMID:
24559766
22.

Economic and environmental characterization of an evolving Li-ion battery waste stream.

Wang X, Gaustad G, Babbitt CW, Bailey C, Ganter MJ, Landi BJ.

J Environ Manage. 2014 Mar 15;135:126-34. doi: 10.1016/j.jenvman.2014.01.021. Epub 2014 Feb 14.

PMID:
24531384
23.

Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.

Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, Mitry E.

Dig Liver Dis. 2014 Mar;46(3):283-6. doi: 10.1016/j.dld.2013.10.012. Epub 2013 Nov 20.

PMID:
24268567
24.

Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, Atochin I, Link DR, Griffiths AD, Pallier K, Blons H, Bouché O, Landi B, Hutchison JB, Laurent-Puig P.

Clin Chem. 2013 Dec;59(12):1722-31. doi: 10.1373/clinchem.2013.206359. Epub 2013 Aug 12.

25.

Prelithiation of silicon-carbon nanotube anodes for lithium ion batteries by stabilized lithium metal powder (SLMP).

Forney MW, Ganter MJ, Staub JW, Ridgley RD, Landi BJ.

Nano Lett. 2013 Sep 11;13(9):4158-63. doi: 10.1021/nl401776d. Epub 2013 Aug 8.

PMID:
23902472
26.

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.

Pernot S, Mitry E, Samalin E, Dahan L, Dalban C, Ychou M, Seitz JF, Turki H, Mazard T, Zaanan A, Lepère C, Vaillant JN, Landi B, Rougier P, Taieb J.

Gastric Cancer. 2014 Apr;17(2):341-7. doi: 10.1007/s10120-013-0266-6. Epub 2013 Jun 6.

PMID:
23739764
27.

Small bowel polypectomy by double balloon enteroscopy: Correlation with prior capsule endoscopy.

Rahmi G, Samaha E, Lorenceau-Savale C, Landi B, Edery J, Manière T, Canard JM, Malamut G, Chatellier G, Cellier C.

World J Gastrointest Endosc. 2013 May 16;5(5):219-25. doi: 10.4253/wjge.v5.i5.219.

28.

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.

Bachet JB, Landi B, Laurent-Puig P, Italiano A, Le Cesne A, Lévy P, Safar V, Duffaud F, Blay JY, Emile JF.

Eur J Cancer. 2013 Jul;49(11):2531-41. doi: 10.1016/j.ejca.2013.04.005. Epub 2013 May 3.

PMID:
23648119
29.

[Gastrointestinal stromal tumors: clinical features and diagnosis].

Landi B.

Bull Acad Natl Med. 2012 Apr-May;196(4-5):845-52; discussion 852-3. Review. French.

PMID:
23550447
30.

Double pancreatic and gastric adenocarcinomas: a rare association.

Kourie HR, Markoutsaki N, Roussel H, Rahmi G, Van der Stiegel M, Palazzo L, Fabre M, Cuenod CA, Dubreuil O, Landi B, Rougier P, Taieb J.

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):e137-40. doi: 10.1016/j.clinre.2012.09.008. Epub 2012 Nov 15.

PMID:
23158953
31.

Chemosensitivity in ovarian metastases from gastric cancer: a case series.

Brieau B, Roussel H, Markoutsaki T, Dubreuil O, Trouilloud I, Landi B, Lepère C, Vaillant JN, Berger A, Rougier P, Taieb J, Zaanan A.

Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):289-95. doi: 10.1016/j.clinre.2012.09.007. Epub 2012 Nov 9.

PMID:
23142590
32.

Preeclampsia: No longer solely a pregnancy disease.

Tranquilli AL, Landi B, Giannubilo SR, Sibai BM.

Pregnancy Hypertens. 2012 Oct;2(4):350-7. doi: 10.1016/j.preghy.2012.05.006. Epub 2012 Jun 15. Review.

PMID:
26105602
33.

PP047. Outpatient management of pregnancy complicated by mild hypertensive disorders.

Giannubilo SR, Bezzeccheri V, Landi B, Battistoni GI, Stortoni P, Vitali P, Tranquilli AL.

Pregnancy Hypertens. 2012 Jul;2(3):267. doi: 10.1016/j.preghy.2012.04.158. Epub 2012 Jun 13.

PMID:
26105371
34.

Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

Cassier PA, Fumagalli E, Rutkowski P, Schöffski P, Van Glabbeke M, Debiec-Rychter M, Emile JF, Duffaud F, Martin-Broto J, Landi B, Adenis A, Bertucci F, Bompas E, Bouché O, Leyvraz S, Judson I, Verweij J, Casali P, Blay JY, Hohenberger P; European Organisation for Research and Treatment of Cancer.

Clin Cancer Res. 2012 Aug 15;18(16):4458-64. Epub 2012 Jun 20.

35.

Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.

Giannubilo SR, Bezzeccheri V, Cecchi S, Landi B, Battistoni GI, Vitali P, Cecchi L, Tranquilli AL.

Arch Gynecol Obstet. 2012 Sep;286(3):637-42. doi: 10.1007/s00404-012-2371-x. Epub 2012 May 12.

PMID:
22581388
36.

High-performance, lightweight coaxial cable from carbon nanotube conductors.

Jarosz PR, Shaukat A, Schauerman CM, Cress CD, Kladitis PE, Ridgley RD, Landi BJ.

ACS Appl Mater Interfaces. 2012 Feb;4(2):1103-9. doi: 10.1021/am201729g. Epub 2012 Feb 9.

PMID:
22272936
37.

The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage.

Giannubilo SR, Landi B, Pozzi V, Sartini D, Cecati M, Stortoni P, Corradetti A, Saccucci F, Tranquilli AL, Emanuelli M.

Cytokine. 2012 Apr;58(1):50-6. doi: 10.1016/j.cyto.2011.12.019. Epub 2012 Jan 21.

PMID:
22266274
38.

Duodenal gangliocytic paraganglioma with lymph node metastasis and an 8-year follow-up: a case report.

Barret M, Rahmi G, Duong van Huyen JP, Landi B, Cellier C, Berger A.

Eur J Gastroenterol Hepatol. 2012 Jan;24(1):90-4. doi: 10.1097/MEG.0b013e32834dfdfa.

PMID:
22081010
39.

Carbon nanotube wires and cables: near-term applications and future perspectives.

Jarosz P, Schauerman C, Alvarenga J, Moses B, Mastrangelo T, Raffaelle R, Ridgley R, Landi B.

Nanoscale. 2011 Nov;3(11):4542-53. doi: 10.1039/c1nr10814j. Epub 2011 Oct 7.

PMID:
21984338
40.

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.

Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, Doucet L, Hostein I, Landi B, Buisine MP, Neuville A, Bouché O, Cervera P, Pretet JL, Tisserand J, Gauthier A, Le Cesne A, Sabourin JC, Scoazec JY, Bonvalot S, Corless CL, Heinrich MC, Blay JY, Aegerter P.

Med Oncol. 2012 Sep;29(3):1765-72. doi: 10.1007/s12032-011-0074-y. Epub 2011 Sep 28.

PMID:
21953054
41.

Long-term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions.

Samaha E, Rahmi G, Landi B, Lorenceau-Savale C, Malamut G, Canard JM, Bloch F, Jian R, Chatellier G, Cellier C.

Am J Gastroenterol. 2012 Feb;107(2):240-6. doi: 10.1038/ajg.2011.325. Epub 2011 Sep 27.

PMID:
21946281
42.

Phase II study of first-line FOLFIRI for progressive metastatic well-differentiated pancreatic endocrine carcinoma.

Brixi-Benmansour H, Jouve JL, Mitry E, Bonnetain F, Landi B, Hentic O, Bedenne L, Cadiot G.

Dig Liver Dis. 2011 Nov;43(11):912-6. doi: 10.1016/j.dld.2011.07.001. Epub 2011 Aug 9.

PMID:
21831734
43.

Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.

Karoui M, Roudot-Thoraval F, Mesli F, Mitry E, Aparicio T, Des Guetz G, Louvet C, Landi B, Tiret E, Sobhani I.

Dis Colon Rectum. 2011 Aug;54(8):930-8. doi: 10.1097/DCR.0b013e31821cced0. Erratum in: Dis Colon Rectum. 2011 Oct;54(10):1338. DesGuetz, Gaetan [corrected to Des Guetz, Gaetan].

PMID:
21730780
44.

Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.

Williet N, Dubreuil O, Boussaha T, Trouilloud I, Landi B, Housset M, Botti M, Rougier P, Belghiti J, Taieb J.

World J Gastroenterol. 2011 May 7;17(17):2255-8. doi: 10.3748/wjg.v17.i17.2255.

45.

Management of gastrointestinal stromal tumours of limited size: proposals from a French panel of physicians.

Landi B, Bouché O, Guimbaud R, Aparicio T, Berger A, Bonvalot S, Buecher B, Blay JY, Boustière C, Coindre JM, Emile JF, Giovannini M, Lecomte T, Le Cesne A, Monges G, Napoléon B, Palazzo L, Chayvialle JA.

Dig Liver Dis. 2011 Dec;43(12):935-9. doi: 10.1016/j.dld.2011.04.008. Epub 2011 May 28.

PMID:
21621493
46.

Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine.

Trouilloud I, Dubreuil O, Boussaha T, Lepère C, Landi B, Zaanan A, Bachet JB, Taieb J.

Clin Res Hepatol Gastroenterol. 2011 May;35(5):364-74. doi: 10.1016/j.clinre.2011.02.002. Epub 2011 Mar 23. Review.

PMID:
21435966
47.

Material and energy intensity of fullerene production.

Anctil A, Babbitt CW, Raffaelle RP, Landi BJ.

Environ Sci Technol. 2011 Mar 15;45(6):2353-9. doi: 10.1021/es103860a. Epub 2011 Feb 18.

PMID:
21332197
48.

Enhanced capacity and rate capability of carbon nanotube based anodes with titanium contacts for lithium ion batteries.

DiLeo RA, Castiglia A, Ganter MJ, Rogers RE, Cress CD, Raffaelle RP, Landi BJ.

ACS Nano. 2010 Oct 26;4(10):6121-31. doi: 10.1021/nn1018494.

PMID:
20857949
49.

The origin of pre-eclampsia: from decidual "hyperoxia" to late hypoxia.

Tranquilli AL, Landi B.

Med Hypotheses. 2010 Jul;75(1):38-46. doi: 10.1016/j.mehy.2010.01.024. Epub 2010 Feb 18.

PMID:
20171021
50.

[Gastrointestinal stromal tumors (GIST)<5 cm in size: review of the literature and expert propositions for clinical management].

Landi B, Bouché O, Guimbaud R, Chayvialle JA.

Gastroenterol Clin Biol. 2010 Feb;34(2):120-33. doi: 10.1016/j.gcb.2009.06.019. Epub 2010 Feb 6. Review. French.

Supplemental Content

Support Center